depression

colorful brain art model
Biotech

Reunion's psychedelic reduces postpartum depression in ph. 2

Reunion’s RE104 reduced the symptoms of postpregnancy depression in a phase 2 study, setting up the biotech to enter a late-stage trial next year.
James Waldron Aug 18, 2025 7:52am
colorful brain art model

Beckley Psytech psychedelic reduces depression symptoms in ph. 2

Jul 1, 2025 8:30am
Arrows hitting targets

Gilgamesh links psychedelic to 94% remission rate in depression

May 27, 2025 11:00am
plan B fail reroute road path trail miss

Neumora rethinks depression drug strategy after ph. 3 failure

Mar 3, 2025 11:00am
forest woods paths paths diverge

Supernus depression drug candidate fails midstage trial

Feb 19, 2025 6:40am
colorful brain art model

Irish biotech's inhaled drug reduces depression in phase 2 trial

Feb 3, 2025 8:15am